950131833	950131833	CD	B-NP	O
|	|	NN	I-NP	O
CHO	CHO	NN	I-NP	O
|	|	NN	I-NP	O
26675684	26675684	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4654588	4654588	CD	B-NP	O
|	|	CC	I-NP	O
3/28/2005	3/28/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
RENAL	RENAL	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/1/2005	10/1/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/15/2005	10/15/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
UZUN	UZUN	NNP	B-NP	O
,	,	,	O	O
CARMELO	CARMELO	NNP	B-NP	O
MD	MD	NNP	I-NP	O
ADMITTING	ADMITTING	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Hypoxia	Hypoxia	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Hypoxia	Hypoxia	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
____	____	NNP	B-NP	O
MS.	MS.	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
61-year-old	61-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
not	not	RB	B-ADVP	O
yet	yet	RB	I-ADVP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
;	;	:	O	O
hypertension	hypertension	NN	B-NP	O
;	;	:	O	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
legally	legally	RB	B-ADJP	O
blind	blind	JJ	I-ADJP	O
;	;	:	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
AV	AV	NN	I-NP	O
fistula	fistula	NN	I-NP	O
placed	place	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Burg	Burg	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
initially	initially	RB	B-ADVP	O
on	on	IN	B-PP	O
3/9/04	3/9/04	CD	B-NP	O
through	through	IN	I-NP	O
5/14/05	5/14/05	CD	I-NP	O
for	for	IN	B-PP	O
hypoglycemic	hypoglycemic	JJ	B-NP	O
arrest	arrest	NN	I-NP	O
,	,	,	O	O
during	during	IN	B-PP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
resuscitated	resuscitate	VBN	I-VP	O
with	with	IN	B-PP	O
full	full	JJ	B-NP	O
mental	mental	JJ	I-NP	O
recovery	recovery	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Carewin	Carewin	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
readmitted	readmitte	VBN	I-VP	O
on	on	IN	B-PP	O
9/16/05	9/16/05	CD	B-NP	O
through	through	IN	B-PP	O
10/10/05	10/10/05	CD	B-NP	O
for	for	IN	B-PP	O
left	left	JJ	B-NP	O
toe	toe	NN	I-NP	O
ulceration	ulceration	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
required	require	VBD	B-VP	O
operating	operating	NN	B-NP	O
room	room	NN	I-NP	O
debridement	debridement	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
intravenous	intravenous	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
p.o.	p.o.	FW	B-NP	O
clindamycin	clindamycin	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
discharged	discharge	VBD	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Mevent	Mevent	NNP	I-NP	O
Healthcare	Healthcare	NNP	I-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
subsequently	subsequently	RB	B-ADVP	O
presented	present	VBD	B-VP	O
on	on	IN	B-PP	O
9/30/05	9/30/05	CD	B-NP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
report	report	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
intermittent	intermittent	JJ	B-NP	O
confusion	confusion	NN	I-NP	O
and	and	CC	I-NP	O
hypoxias	hypoxia	NNS	I-NP	O
to	to	TO	B-PP	O
85	85	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Medar	Medar	NNP	I-NP	O
Emnew	Emnew	NNP	I-NP	O
Litvange	Litvange	NNP	I-NP	O
Troyettedea	Troyettedea	NNP	I-NP	O
Region	Region	NNP	I-NP	O
General	General	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
normotensive	normotensive	JJ	B-ADJP	O
at	at	IN	B-PP	O
138/83	138/83	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
O2	O2	NN	I-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
88	88	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
augmented	augment	VBD	B-VP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
nonrebreather	nonrebreather	NN	B-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
examination	examination	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
,	,	,	O	O
two-thirds	two-third	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
way	way	NN	I-NP	O
up	up	RP	B-PRT	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
is	be	VBZ	B-VP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
,	,	,	O	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
laboratory	laboratory	NN	B-NP	O
values	value	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
were	be	VBD	B-VP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
18	18	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
up	up	RP	B-PRT	O
of	of	IN	B-PP	O
54	54	CD	B-NP	O
,	,	,	O	O
elevated	elevate	VBN	B-VP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
creatinine	creatinine	NN	I-NP	O
reading	read	VBG	B-VP	O
on	on	IN	B-PP	O
10/10/05	10/10/05	CD	B-NP	O
of	of	IN	B-PP	O
2.7	2.7	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
brain	brain	NN	I-NP	O
natriuretic	natriuretic	JJ	I-NP	O
peptide	peptide	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
at	at	IN	B-PP	O
2200	2200	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
General	General	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
attending	attend	VBG	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Clarence	Clarence	NNP	I-NP	O
Stephan	Stephan	NNP	I-NP	O
Cler	Cler	NNP	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
and	and	CC	I-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Remarkable	Remarkable	NNP	B-NP	O
for	for	IN	B-PP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
AV	AV	NN	I-NP	O
fistula	fistula	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
,	,	,	O	O
not	not	RB	B-ADVP	O
yet	yet	RB	I-ADVP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
legally	legally	RB	B-ADJP	O
blind	blind	JJ	I-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
recent	recent	JJ	B-NP	O
right	right	JJ	I-NP	O
toe	toe	NN	I-NP	O
ulceration	ulceration	NN	I-NP	O
,	,	,	O	O
requiring	require	VBG	B-VP	O
operating	operate	VBG	B-NP	O
room	room	NN	I-NP	O
debridement	debridement	NN	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
,	,	,	O	O
calcitriol	calcitriol	NN	B-NP	O
,	,	,	O	O
PhosLo	PhosLo	NN	B-NP	B-protein
,	,	,	O	O
calcium	calcium	NN	B-NP	O
carbonate	carbonate	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NN	B-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
,	,	,	O	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
levothyroxine	levothyroxine	NN	B-NP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
timolol	timolol	NN	B-NP	O
,	,	,	O	O
amlodipine	amlodipine	NN	B-NP	O
,	,	,	O	O
Dilantin	Dilantin	NN	B-NP	B-protein
,	,	,	O	O
Protonix	Protonix	NN	B-NP	O
,	,	,	O	O
clindamycin	clindamycin	NN	B-NP	O
,	,	,	O	O
Cozaar	Cozaar	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Lasix	Lasix	NNP	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
penicillin	penicillin	NN	B-NP	B-protein
and	and	CC	I-NP	O
metolazone	metolazone	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Not	Not	RB	B-ADJP	O
significant	significant	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
previously	previously	RB	I-VP	O
residing	reside	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Nstrop	Nstrop	NNP	I-NP	O
Roll	Roll	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
LABORATORY	LABORATORY	NNP	I-NP	O
DATA	DATA	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
laboratory	laboratory	NN	I-NP	O
panel	panel	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
includes	include	VBZ	B-VP	O
sodium	sodium	NN	B-NP	O
of	of	IN	B-PP	O
133	133	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
of	of	IN	B-PP	O
5.4	5.4	CD	B-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
of	of	IN	B-PP	O
103	103	CD	B-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
of	of	IN	B-PP	O
21	21	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
,	,	,	O	O
elevated	elevate	VBN	B-VP	O
from	from	IN	B-PP	O
53	53	CD	B-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
;	;	:	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
5.4	5.4	CD	B-NP	O
,	,	,	O	O
elevated	elevate	VBN	B-VP	O
from	from	IN	B-PP	O
2.7	2.7	CD	B-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
;	;	:	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
43	43	CD	B-NP	O
;	;	:	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
10.5	10.5	CD	B-NP	O
;	;	:	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
25.4	25.4	CD	B-NP	O
,	,	,	O	O
down	down	RB	B-ADVP	O
from	from	IN	B-PP	O
28.9	28.9	CD	B-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
;	;	:	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
315	315	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
;	;	:	O	O
INR	INR	NN	B-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
film	film	NN	I-NP	O
as	as	IN	B-PP	O
mentioned	mention	VBN	B-NP	O
previously	previously	RB	I-NP	O
demonstrated	demonstrate	VBN	I-NP	O
prominent	prominent	JJ	I-NP	O
bibasilar	bibasilar	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
vasculature	vasculature	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
and	and	CC	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

Prior	Prior	JJ	B-NP	O
creatinine	creatinine	NN	I-NP	O
measured	measure	VBN	B-VP	O
at	at	IN	B-PP	O
2-3	2-3	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
creatinine	creatinine	NN	I-NP	B-protein
was	be	VBD	B-VP	I-protein
5.4	5.4	CD	B-NP	I-protein
.	.	.	O	O

Peak	Peak	JJ	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
at	at	IN	B-PP	O
6.0	6.0	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Renal	Renal	NNP	I-NP	O
Consult	Consult	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
gadolinium-induced	gadolinium-induced	JJ	B-NP	O
nephropathy	nephropathy	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
and	and	CC	O	O
recent	recent	JJ	B-NP	O
MRA	MRA	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
obtained	obtain	VBN	I-VP	O
to	to	TO	I-VP	O
evaluate	evaluate	VB	I-VP	O
for	for	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
significantly	significantly	RB	B-NP	O
volume	volume	NN	I-NP	O
overloaded	overload	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
weight	weight	NN	I-NP	O
up	up	RB	B-ADVP	O
approximately	approximately	RB	B-NP	O
50	50	CD	I-NP	O
pounds	pound	NNS	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
value	value	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
congestion	congestion	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
with	with	IN	B-PP	O
Diuril	Diuril	NNP	B-NP	O
support	support	NN	I-NP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
volume	volume	NN	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
diuresed	diurese	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Admission	Admission	NN	B-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
at	at	IN	B-PP	O
129.9	129.9	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
95.6	95.6	CD	B-NP	O
kg	kg	NN	I-NP	O
,	,	,	O	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
her	her	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

Recommend	Recommend	VB	B-VP	O
further	further	JJ	B-NP	O
outpatient	outpatient	NN	I-NP	O
titration	titration	NN	I-NP	O
and	and	CC	I-NP	O
Lasix	Lasix	NN	I-NP	O
dosing	dosing	NN	I-NP	O
as	as	IN	B-SBAR	O
required	require	VBN	B-VP	O
to	to	TO	I-VP	O
maintain	maintain	VB	I-VP	O
her	her	PRP$	B-NP	O
ins	in	NNS	I-NP	O
and	and	CC	O	O
outs	out	VBZ	B-VP	O
at	at	IN	B-PP	O
approximately	approximately	RB	B-NP	O
even	even	RB	I-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
fluid-restricted	fluid-restricted	JJ	I-NP	O
diet	diet	NN	I-NP	O
of	of	IN	B-PP	O
2.5	2.5	CD	B-NP	O
liters	liter	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
nephrologist	nephrologist	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Sir	Sir	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
discharge	discharge	NN	I-NP	O
instructions	instruction	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
as	as	IN	B-SBAR	O
previously	previously	RB	B-ADVP	O
described	describe	VBN	B-VP	O
.	.	.	O	O

Recommend	Recommend	VB	B-VP	O
outpatient	outpatient	NN	B-NP	O
evaluation	evaluation	NN	I-NP	O
as	as	IN	B-SBAR	O
required	require	VBN	B-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
hypoxia	hypoxia	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
acute	acute	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
congestion	congestion	NN	I-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
significant	significant	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hypoxia	hypoxia	NN	I-NP	O
resolved	resolve	VBD	B-VP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
with	with	IN	B-PP	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
desaturation	desaturation	NN	I-NP	O
occurring	occur	VBG	B-VP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
while	while	IN	B-SBAR	O
sleeping	sleeping	NN	B-NP	O
,	,	,	O	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
peripheral	peripheral	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

Recommend	Recommend	VB	B-VP	O
further	further	JJ	B-NP	O
outpatient	outpatient	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
and	and	CC	O	O
supplemental	supplemental	JJ	B-NP	O
oxygenation	oxygenation	NN	I-NP	O
as	as	IN	B-SBAR	O
required	require	VBN	B-VP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
both	both	CC	O	O
iron	iron	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Epogen	Epogen	NN	B-NP	O
and	and	CC	I-NP	O
iron	iron	NN	I-NP	O
supplementation	supplementation	NN	I-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
bilateral	bilateral	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
hypoxia	hypoxia	NN	B-NP	O
,	,	,	O	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
.	.	.	O	O

Lower	Low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
noninvasive	noninvasive	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
is	be	VBZ	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
clot	clot	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
,	,	,	O	O
maintained	maintain	VBN	B-VP	O
on	on	IN	B-PP	O
Levoxyl	Levoxyl	NN	B-NP	O
.	.	.	O	O

Recommend	Recommend	VB	B-VP	O
outpatient	outpatient	NN	B-NP	O
evaluation	evaluation	NN	I-NP	O
as	as	IN	B-SBAR	O
required	require	VBN	B-VP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
maintained	maintain	VBN	B-VP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
with	with	IN	B-PP	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
supplementation	supplementation	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
NPH	NPH	NN	I-NP	B-protein
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
12	12	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
with	with	IN	B-PP	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
supplementation	supplementation	NN	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

Recommend	Recommend	NN	B-NP	O
titration	titration	NN	I-NP	O
as	as	IN	B-SBAR	O
required	require	VBN	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
A1c	A1c	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
7.5	7.5	CD	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
or	or	CC	O	O
low	low	JJ	B-NP	O
p.o.	p.o.	FW	I-NP	O
intake	intake	NN	I-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
we	we	PRP	B-NP	O
would	would	MD	B-VP	O
recommend	recommend	VB	I-VP	O
caution	caution	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
5000	5000	CD	B-NP	O
units	unit	NNS	I-NP	O
t.i.d.	t.i.d.	VBN	B-VP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Musculoskeletal	Musculoskeletal	JJ	B-ADJP	O
:	:	:	O	O
Recommend	Recommend	VB	B-VP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Code	Code	NN	B-NP	O
status	status	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
adamantly	adamantly	RB	B-ADVP	O
DNR/DNI	DNR/DNI	NN	I-ADVP	O
per	per	IN	B-PP	O
her	her	PRP$	B-NP	O
own	own	JJ	I-NP	O
wishes	wish	NNS	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
noted	note	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
persistent	persistent	JJ	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
with	with	IN	B-PP	O
minor	minor	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

C.	C.	FW	B-NP	O
diff	diff	FW	I-NP	O
colitis	colitis	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
two-week	two-week	JJ	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
Flagyl	Flagyl	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

x14	x14	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
given	give	VBN	B-NP	O
concern	concern	NN	I-NP	O
initially	initially	RB	B-ADVP	O
for	for	IN	B-PP	O
right	right	RB	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
14-course	14-course	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
titrated	titrate	VBN	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
food	food	NN	B-NP	O
and	and	CC	O	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
transferred	transfer	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Du	Du	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
.	.	.	O	O

FOLLOW	FOLLOW	JJ	B-NP	O
UP	UP	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Goodpaster	Goodpaster	NNP	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
SNHO	SNHO	NNP	I-NP	O
Freoaknafre	Freoaknafre	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
follow-up	follow-up	JJ	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
THHC	THHC	NNP	B-NP	O
Nephrology	Nephrology	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Jesus	Jesus	NNP	I-NP	O
Linardi	Linardi	NNP	I-NP	O
,	,	,	O	O
scheduled	schedule	VBN	B-VP	O
for	for	IN	B-PP	O
10/3/05	10/3/05	CD	B-NP	O
at	at	IN	B-PP	O
11	11	CD	B-NP	O
a.m.	a.m.	RB	I-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
0-4089281	0-4089281	CD	B-NP	O
EMS	EMS	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
ZECH	ZECH	NN	B-NP	B-protein
,	,	,	O	O
ELLIOT	ELLIOT	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BEDAR	BEDAR	NNP	B-NP	O
,	,	,	O	O
MAX	MAX	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
1190970	1190970	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
8/29/05	8/29/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/29/05	8/29/05	CD	B-NP	O

